WASHINGTON — The U.S. Environmental Protection Agency has moved to tighten oversight of a chemical used in tires, a compound now linked to mass salmon die-offs and potentially to Alzheimer’s disease. The regulatory calculus is shifting. At the center of the issue is 6PPD, an antioxidant added to tire rubber.
When tires wear down on roadways, 6PPD transforms into 6PPD-quinone, or 6PPD-Q, a chemical that has proven acutely toxic to coho salmon. The broader stakes extend into human health, as emerging research suggests a possible connection between 6PPD-Q and neurological decline.
The EPA’s first major step came in 2022, when the agency added 6PPD to its list of chemicals for risk evaluation under the Toxic Substances Control Act. That designation triggers a formal process to determine whether the chemical presents an unreasonable risk to human health or the environment. Then, in November 2023, the EPA announced a proposed rule under TSCA that would require manufacturers and processors of 6PPD to report on its use and environmental release.
This is not a ban — not yet. Strategically, it is a data-collection move, designed to give regulators a clearer picture of how much of the chemical is out there, where it ends up, and what pathways exist for human and ecological exposure.
The tire industry has not been silent. The U.S. Tire Manufacturers Association has acknowledged the problem and stated it is actively researching alternatives to 6PPD. That is a significant concession from an industry that relies on the compound to extend tire life and prevent blowouts.
Finding a substitute that matches 6PPD’s performance, cost, and safety profile will be no small engineering challenge. What this signals is that the industry sees the regulatory writing on the wall.
State-Level Action Precedes Federal Movement
While the EPA has moved methodically, two West Coast states have already jumped ahead. California’s Department of Toxic Substances Control began investigating 6PPD in 2023 as a potential candidate for regulation under the Safer Consumer Products program. That program is among the nation’s most aggressive state-level chemical regulatory frameworks, and it has a history of forcing national reformulations of consumer goods.
Washington State has also studied the impact of 6PPD-Q on salmon and considered restrictions. The connection is visceral there: coho salmon returning to urban streams in the Puget Sound region have been observed dying within hours of exposure to stormwater runoff containing 6PPD-Q.
The fish flip onto their backs, swim in circles, and die. For a state where salmon are both an ecological keystone species and a cultural touchstone for tribal nations, the political pressure to act is immense. These state actions create a patchwork of regulations that complicate national supply chains.
Strategically, the EPA’s federal rulemaking can preempt that patchwork — but only if it moves quickly enough.
The Alzheimer’s Connection Changes the Calculation
The potential link between 6PPD-Q and Alzheimer’s disease may accelerate regulatory action significantly. While the source material does not detail the specific research or findings, the mere existence of a possible connection to a devastating neurodegenerative condition that affects millions of Americans raises the stakes far beyond salmon preservation. The calculus for regulators shifts when a chemical is tied to a disease that costs the U.S. healthcare system hundreds of billions of dollars annually.
Environmental groups and public health advocates will almost certainly use this connection to push for faster and more aggressive action from the EPA, including potential restrictions or phaseouts. What remains unclear is how quickly the science will solidify.
The EPA’s risk evaluation under TSCA is a multi-year process, and the proposed rule on reporting is still working its way through the federal rulemaking pipeline. The Alzheimer’s link, if confirmed by further studies, could compress that timeline.
What to Watch Next
The key date to watch is the finalization of the EPA’s reporting rule for 6PPD manufacturers and processors. Once that data is in hand, the agency will have a far clearer picture of the chemical’s footprint. From there, the question becomes whether the EPA moves toward regulation, restriction, or an outright ban.
The tire industry’s search for alternatives will also bear close watching. If a viable substitute emerges, the path to regulation becomes politically easier.
If not, the industry and the agency could find themselves in a prolonged conflict over costs, safety, and timelines. For now, the EPA has laid its pieces on the board. The state of Washington and California have made their moves.
And the emerging science on Alzheimer’s may yet prove to be the factor that reshapes the entire game.
